RSS Feeds
Genetic Risk Assessment and BRCA Mutation Testing
- Ned Calonge, MD, MPH; and
- Diana B. Petitti, MD, MPH
- From the U.S. Preventive Services Task Force, Denver, CO 80246, and Pasadena, CA 91888.
IN RESPONSE:
We appreciate Dr. Eisinger's and Dr. Horsman's concerns about the USPSTF recommendation for BRCA screening. First, they take issue with the Task Force's use of the term “increased risk” as a criterion for offering testing. This may have more to do with semantics than substance. Clinical criteria that suggest a woman is “at risk” for breast or ovarian cancer as defined by Drs. Eisinger and Horsman might mean she is “at increased risk” according to USPSTF nomenclature. The Task Force recommends that any woman “at increased risk” be referred …
